The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Thromboembolic complications in atrial fibrillation.
Abstract
I review the present understanding of thromboembolic complications and their prevention in patients with nonrheumatic atrial fibrillation. Chronic atrial fibrillation carries an annual 3-6% risk of thromboembolic complications, which is 5-7 times greater than that of controls with sinus rhythm. Paroxysmal atrial fibrillation is associated with a lower risk of thromboembolic complications than chronic atrial fibrillation. Heart failure and systemic hypertension seem to be significant clinical risk factors for stroke in patients with atrial fibrillation, but disagreement persists, and, with few exceptions, subgroups at particular risk have not been convincingly identified. The risk of stroke in persons with thyrotoxic atrial fibrillation seems to be lower than believed previously. Clinical studies have shown that left atrial dilatation is a consequence of the duration of atrial fibrillation rather than a cause, but the relation of left atrial enlargement to stroke is uncertain. Cerebral blood flow may be reduced during atrial fibrillation but seems to increase after cardioversion to sinus rhythm. A high prevalence of silent cerebral infarction has been detected in patients with chronic atrial fibrillation, but there seems to be a low risk of silent cerebral infarction in persons with paroxysmal atrial fibrillation. The one prospective study published to date on stroke prevention in patients with nonrheumatic chronic atrial fibrillation showed that anticoagulation with warfarin significantly reduced the incidence of thromboembolic complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The fiamingham Study
Wolf, P. A., Dawber, T. R., Thomas, H. E., & Kannel, W. B. (1978) · Neurology · doi:10.1212/wnl.28.10.973 · Cited by 1,526
Systemic Embolism and Anticoagulant Prophylaxis in Rheumatic Heart Disease
Szekely, P. (1964) · BMJ · doi:10.1136/bmj.1.5392.1209 · Cited by 325
Atrial fibrillation and stroke: new ideas, persisting dilemmas
Halperin, J. L., & Hart, R. G. (1988) · Stroke · doi:10.1161/01.str.19.8.937 · Cited by 231
Cited by
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000041 · Cited by 7,115
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.022 · Cited by 2,955
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177292 · Cited by 2,805
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary
Fuster, V., Rydén, L. E., Asinger, R. W., Cannom, D. S., Crijns, H. J., Frye, R. L., Halperin, J. L., Kay, G. N., Klein, W. W., Lévy, S., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01587-x · Cited by 1,348
Antithrombotic Therapy for Atrial Fibrillation
Lip, G. Y. H., Banerjee, A., Boriani, G., Chiang, C. E., Fargo, R., Freedman, B., Lane, D. A., Ruff, C. T., Turakhia, M., Werring, D., et al. (2018) · Chest · doi:10.1016/j.chest.2018.07.040 · Cited by 939
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Kay, G. N., Le Huezey, J.-Y., Lowe, J. E., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.013 · Cited by 924
Antithrombotic Therapy for Atrial Fibrillation
You, J. J., Singer, D. E., Howard, P. A., Lane, D. A., Eckman, M. H., Fang, M. C., Hylek, E. M., Schulman, S., Go, A. S., Hughes, M., et al. (2012) · Chest · doi:10.1378/chest.11-2304 · Cited by 918
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Kay, G. N., Le Huezey, J.-Y., Lowe, J. E., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318214876d · Cited by 859
Antithrombotic Therapy in Atrial Fibrillation
Singer, D. E., Albers, G. W., Dalen, J. E., Fang, M. C., Go, A. S., Halperin, J. L., Lip, G. Y. H., & Manning, W. J. (2008) · Chest · doi:10.1378/chest.08-0678 · Cited by 751
Atrial Fibrillation and Dementia in a Population-Based Study: The Rotterdam Study
Ott, A., Breteler, M. M. B., de Bruyne, M. C., van Harskamp, F., Grobbee, D. E., & Hofman, A. (1997) · Stroke · doi:10.1161/01.str.28.2.316 · Cited by 732
Writing Committee Members, Fuster, V., Ryden, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., et al. (2006) · Europace · doi:10.1093/europace/eul097 · Cited by 667
Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy
Hart, R. G., Pearce, L. A., Rothbart, R. M., McAnulty, J. H., Asinger, R. W., & Halperin, J. L. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00489-1 · Cited by 663
Brain–Heart Interaction: Cardiac Complications After Stroke
Chen, Z., Venkat, P., Seyfried, D., Chopp, M., Yan, T., & Chen, J. (2017) · Circulation Research · doi:10.1161/circresaha.117.311170 · Cited by 558
Antithrombotic Therapy in Atrial Fibrillation
Singer, D. E., Albers, G. W., Dalen, J. E., Go, A. S., Halperin, J. L., & Manning, W. J. (2004) · Chest · doi:10.1378/chest.126.3_suppl.429s · Cited by 547
Björck, M., Earnshaw, J. J., Acosta, S., Bastos Gonçalves, F., Cochennec, F., Debus, E. S., Hinchliffe, R., Jongkind, V., Koelemay, M. J. W., Menyhei, G., et al. (2020) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2019.09.006 · Cited by 544
Acute Stroke With Atrial Fibrillation: The Copenhagen Stroke Study
Jørgensen, H. S., Nakayama, H., Reith, J., Raaschou, H. O., & Olsen, T. S. (1996) · Stroke · doi:10.1161/01.str.27.10.1765 · Cited by 522
(2001) · European Heart Journal · doi:10.1053/euhj.2001.2983 · Cited by 494
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.018 · Cited by 467
Estrogen as a Neuroprotectant in Stroke
Hurn, P. D., & Macrae, I. M. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200004000-00001 · Cited by 401
Arnold, A. Z., Mick, M. J., Mazurek, R. P., Loop, F. D., & Trohman, R. G. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90530-z · Cited by 392
Antithrombotic Therapy in Atrial Fibrillation
Albers, G. W., Dalen, J. E., Laupacis, A., Manning, W. J., Petersen, P., & Singer, D. E. (2001) · Chest · doi:10.1378/chest.119.1_suppl.194s · Cited by 360
Self-citationMügge, A., Kühn, H., Nikutta, P., Grote, J., G. Lopez, J. A., & Daniel, W. G. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90743-9 · Cited by 337
Manning, W. J., Silverman, D. I., Gordon, S., Krumholz, H. M., & Douglas, P. S. (1993) · New England Journal of Medicine · doi:10.1056/nejm199303183281102 · Cited by 330
Manning, W. J., Silverman, D. I., Keighley, C. S., Oettgen, P., & Douglas, P. S. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)00560-d · Cited by 324
Kimura, K. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.048827 · Cited by 321
Minireview: Neuroprotective Effects of Estrogen--New Insights into Mechanisms of Action
Wise, P. M. (2001) · Endocrinology · doi:10.1210/en.142.3.969 · Cited by 259
Sandercock, P., Bamford, J., Dennis, M., Burn, J., Slattery, J., Jones, L., Boonyakarnkul, S., & Warlow, C. (1992) · BMJ · doi:10.1136/bmj.305.6867.1460 · Cited by 255
Thyroid Diseases and Cerebrovascular Disease
Squizzato, A., Gerdes, V. E. A., Brandjes, D. P. M., Büller, H. R., & Stam, J. (2005) · Stroke · doi:10.1161/01.str.0000181772.78492.07 · Cited by 236
Atrial Fibrillation Is Associated With Lower Cognitive Performance in the Framingham Offspring Men
Elias, M. F., Sullivan, L. M., Elias, P. K., Vasan, R. S., D’Agostino, R. B., Seshadri, S., Au, R., Wolf, P. A., & Benjamin, E. J. (2006) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2006.05.009 · Cited by 80
Metadata
- Authors
- Petersen, P.
- Venue
- Stroke
- Published
- 1990-01
- Volume
- 21
- Issue
- 1
- Pages
- 4-13
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2031979004
- Cited by
- 193
- References
- 3
- FWCI
- 9.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.